Biopharma SPAC Jiya Acquisition prices $100M IPO

 

• Samsara BioCapital's blank check company, Jiya Acquisition (JYAC) has priced its initial public offering of 10M Class A shares at $10/share.
• Underwriters' over-allotment is an additional 1.5M Class A shares.
• Shares kicked-off trading today on Nasdaq.
• SPAC intends to focus its search for a target business operating in the biotechnology and pharmaceuticals sector.
• Press release
• https://seekingalpha.com/news/3637987-biopharma-spac-jiya-acquisition-prices-100m-ipo